60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.460
-0.030 (-2.01%)
Jun 1, 2026, 4:00 PM EDT - Market closed
SXTP Revenue
60 Degrees Pharmaceuticals had revenue of $162.09K in the quarter ending March 31, 2026, a decrease of -36.75%. This brings the company's revenue in the last twelve months to $1.31M, up 63.89% year-over-year. In the year 2025, 60 Degrees Pharmaceuticals had annual revenue of $1.41M with 106.81% growth.
Revenue (ttm)
$1.31M
Revenue Growth
+63.89%
P/S Ratio
2.95
Revenue / Employee
$438,301
Employees
3
Market Cap
3.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.41M | 727.75K | 106.81% |
| Dec 31, 2024 | 681.35K | 427.77K | 168.70% |
| Dec 31, 2023 | 253.57K | -257.64K | -50.40% |
| Dec 31, 2022 | 511.21K | -5.84M | -91.95% |
| Dec 31, 2021 | 6.35M | 3.80M | 149.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSXTP News
- 6 days ago - 60 Degrees announces early enrollment of first patient in trial of tafenoquine - TheFly
- 6 days ago - 60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis - GlobeNewsWire
- 12 days ago - H.C. Wainwright downgrades 60 Degrees on ‘untenable’ spending - TheFly
- 12 days ago - 60 Degrees Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 17 days ago - 60 Degrees Pharmaceuticals Announces First Quarter 2026 Results - GlobeNewsWire
- 17 days ago - 60 Degrees Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 17 days ago - 60 Degrees Pharmaceuticals Earnings release: Q1 2026 - Filings
- 6 weeks ago - 60 Degrees Pharmaceuticals Transcript: Biotech Resurgence: Platforms and Pipelines of Today's Innovators - Transcripts